Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice
Abstract Several Zika virus (ZIKV) vaccine candidates have recently been described which use inactivated whole virus, DNA or RNA that express the virus’ Envelope (E) glycoprotein as the antigen. These were successful in stimulating production of virus-targeted antibodies that protected animals again...
Guardado en:
Autores principales: | Ming Yang, Huafang Lai, Haiyan Sun, Qiang Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b021c12dcb5343079ddb8bba37280890 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies
por: Emily N. Gallichotte, et al.
Publicado: (2019) -
Immunological Analysis of Nodavirus Capsid Displaying the Domain III of Japanese Encephalitis Virus Envelope Protein
por: Kiven Kumar, et al.
Publicado: (2021) -
Neutralization mechanism of a highly potent antibody against Zika virus
por: Shuijun Zhang, et al.
Publicado: (2016) -
Single dose of a replication-defective vaccinia virus expressing Zika virus-like particles is protective in mice
por: Brittany Jasperse, et al.
Publicado: (2021) -
A super-potent tetramerized ACE2 protein displays enhanced neutralization of SARS-CoV-2 virus infection
por: Ami Miller, et al.
Publicado: (2021)